Introduced
by
To prohibit pharmacies or a pharmacists from entering a contract that forbids their telling customers the current selling price of other brand name or generic versions of a drug, or interchangeable biological drug products. The bill would also let pharmacists provide certain price information without having to be asked.
Referred to the Committee on Health Policy
Reported without amendment
Without amendment and with the recommendation that the bill pass.
Passed in the House 106 to 1 (details)
Referred to the Committee on Health Policy and Human Services
Reported without amendment
With the recommendation that the substitute (S-1) be adopted and that the bill then pass.
Passed in the Senate 38 to 0 (details)
To prohibit pharmacies or a pharmacists from entering a contract that forbids their telling customers the current selling price of other brand name or generic versions of a drug, or interchangeable biological drug products. The bill would also let pharmacists provide certain price information without having to be asked.
Passed in the House 103 to 2 (details)
To concur with the Senate-passed version of the bill.
